Медицина и инновацииМ Сабиров, О Скосырева +12021
MODERN APPROACHES TO DRUG TREATMENT OF OBESITY
Шагазатова Б.Х. · Кудратова Н.А.
ЦЕНТРАЛЬНО АЗИАТСКИЙ ЭНДОКРИНОЛОГИЧЕСКИЙ ЖУРНАЛ · 2023
Аннотация
Obesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease. Although behavioral therapy is important in treating obesity, it is difficult to reach the ideal weight and maintain long-term weight loss on its own. Therefore, obesity guidelines strongly recommend initiation of medication therapy in patients with BMI ≥30 kg/m 2 and BMI ≥27 kg/m 2 with concomitant weight-related diseases, such as DM2. There is ample evidence to support that pharmacotherapy combined with behavioral interventions can lead to significant weight loss and improved cardiometabolism. One strategy for long-term control of obesity is that weight loss medications should be individualized for each patient, depending on their comorbidities and preferences.
Доказательный фрагмент
«Obesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease.»
Образец извлечения
Демо-превьюObesity is a chronic and relapsing disease that not only disrupts metabolism, but is also a risk factor for cardiovascular disease. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.
Смежные источники
in LibraryХамраев А.Ж., Эминов Р.И.2026
Медицина и инновацииВ Солдатов, Л Солдатова +12013
Медицина, педагогика и технологии: теория и практикаТЕОРИЯ И ПРАКТИКА, Ne’matova F.O. +12024